Highlights from the Latest Articles In Pharmacogenomics of Solid organ Transplantation
- 1 May 2014
- journal article
- Published by Taylor & Francis in Pharmacogenomics
- Vol. 15 (7) , 905-907
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Impact of POR*28 on the Pharmacokinetics of Tacrolimus and Cyclosporine A in Renal Transplant PatientsTherapeutic Drug Monitoring, 2014
- Impact of the CYP3A5, CYP3A4, COMT, IL-10 and POR Genetic Polymorphisms on Tacrolimus Metabolism in Chinese Renal Transplant RecipientsPLOS ONE, 2014
- Effect of different tacrolimus levels on early outcomes after kidney transplantationAnnals of Transplantation, 2014
- Impact of CYP3A5 Genotype on Tacrolimus Versus Midazolam Clearance in Renal Transplant Recipients: New Insights in CYP3A5-Mediated Drug MetabolismPharmacogenomics, 2013
- Tacrolimus trough levels after month 3 as a predictor of acute rejection following kidney transplantation: a lesson learned from DeKAF GenomicsTransplant International, 2013
- Genes and Beans: Pharmacogenomics of Renal TransplantPharmacogenomics, 2013
- Effect of the P450 oxidoreductase *28 polymorphism on the pharmacokinetics of tacrolimus in Chinese healthy male volunteersEuropean Journal of Clinical Pharmacology, 2012
- In Vivo CYP3A4 Activity, CYP3A5 Genotype, and Hematocrit Predict Tacrolimus Dose Requirements and Clearance in Renal Transplant PatientsClinical Pharmacology & Therapeutics, 2012
- The P450 Oxidoreductase*28SNP is Associated with Low Initial Tacrolimus Exposure and Increased Dose Requirements in CYP3A5-Expressing Renal RecipientsPharmacogenomics, 2011
- The P450 oxidoreductase genotype is associated with CYP3A activity in vivo as measured by the midazolam phenotyping testPharmacogenetics and Genomics, 2009